// App-Quantinova.ai

PB2113 : Effectiveness and Safety of Enoxaparin in Patients with Active Cancer and Venous Thromboembolism (VTE): A Systematic Literature Review

Researchers

Presenter

  • J. Shan

Principal Investigators

  • T. Sayre

  • K. Hofer

  • E.T. Shojaei

Medical Centers

  • Sanofi, Global Medical Affairs, Paris, France

  • Doctor Evidence LLC, Santa Monica, United States

  • Evidinno Outcomes Research Inc., Vancouver, BC, Canada

Locations

  • France

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved